← Evidence map

ArticleAnnals of internal medicine2022

In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes.

Kaitlin J Mayne et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35500259